Pharvaris logo

Pharvaris

Pharvaris is a preclinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (HAE) and other B2 receptor-mediated indications.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://pharvaris.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
Leiden Bio Science Park J.H. Oortweg 21 2333 BD
Leiden
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]